Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

about

Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

Item

http://www.wikidata.org/entity/Q41108422

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Outcomes after sofosbuvir-cont ...... cirrhosis: a real-world study

@en

type

Item

label

Outcomes after sofosbuvir-cont ...... cirrhosis: a real-world study

@en

prefLabel

Outcomes after sofosbuvir-cont ...... cirrhosis: a real-world study

@en

P1476

Outcomes after sofosbuvir-cont ...... cirrhosis: a real-world study

@en

P2093

Burong Li

http://www.w3.org/2001/XMLSchema#string

Changyin Tian

http://www.w3.org/2001/XMLSchema#string

Dan Bai

http://www.w3.org/2001/XMLSchema#string

Hong Deng

http://www.w3.org/2001/XMLSchema#string

Shengbang Wang

http://www.w3.org/2001/XMLSchema#string

Shuangsuo Dang

http://www.w3.org/2001/XMLSchema#string

Wenjun Wang

http://www.w3.org/2001/XMLSchema#string

Wenxue Zhao

http://www.w3.org/2001/XMLSchema#string

Zongfang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis.

Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis.

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis

The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States

Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study.

Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease.

Epidemiology and natural history of HCV infection.

P2888

s13027-017-0158-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13027-017-0158-1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fan-pu Ji

P577

2017-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091612413

http://www.w3.org/2001/XMLSchema#string

P698

28924449

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

5598030

http://www.w3.org/2001/XMLSchema#string